AIT Reports First Quarter 2017 Results

AIT is an emerging biopharmaceutical company focused on the design and development of a nitric oxide (NO) formulation and delivery systems

to treat various respiratory diseases announced on May 15, 2017 its financial results for the first quarter of 2017.

Q1/17 Financial Data